347 related articles for article (PubMed ID: 24875217)
1. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
Liu Q; Zhou H; Langdon WY; Zhang J
Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
[TBL] [Abstract][Full Text] [Related]
2. Regulation of immune responses by E3 ubiquitin ligase Cbl-b.
Tang R; Langdon WY; Zhang J
Cell Immunol; 2019 Jun; 340():103878. PubMed ID: 30442330
[TBL] [Abstract][Full Text] [Related]
3. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
[TBL] [Abstract][Full Text] [Related]
4. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
5. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
[TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.
Jafari D; Mousavi MJ; Keshavarz Shahbaz S; Jafarzadeh L; Tahmasebi S; Spoor J; Esmaeilzadeh A
Clin Exp Immunol; 2021 Apr; 204(1):14-31. PubMed ID: 33306199
[TBL] [Abstract][Full Text] [Related]
7. Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy.
Hu X; Li E; Zhou Y; You Q; Jiang Z
Bioorg Med Chem; 2024 Mar; 102():117677. PubMed ID: 38457911
[TBL] [Abstract][Full Text] [Related]
8. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
Loeser S; Penninger JM
Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
[TBL] [Abstract][Full Text] [Related]
9. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.
Qiao G; Zhao Y; Li Z; Tang PQ; Langdon WY; Yang T; Zhang J
J Immunol; 2013 Jul; 191(2):632-9. PubMed ID: 23749633
[TBL] [Abstract][Full Text] [Related]
10. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
[TBL] [Abstract][Full Text] [Related]
11. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin E3 ligase Cbl-b in T cells tolerance and tumor immunity.
Loeser S; Penninger JM
Cell Cycle; 2007 Oct; 6(20):2478-85. PubMed ID: 17704644
[TBL] [Abstract][Full Text] [Related]
13. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G
Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b.
Peschard P; Kozlov G; Lin T; Mirza IA; Berghuis AM; Lipkowitz S; Park M; Gehring K
Mol Cell; 2007 Aug; 27(3):474-85. PubMed ID: 17679095
[TBL] [Abstract][Full Text] [Related]
15. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
[TBL] [Abstract][Full Text] [Related]
16. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b.
Qiao G; Li Z; Molinero L; Alegre ML; Ying H; Sun Z; Penninger JM; Zhang J
Mol Cell Biol; 2008 Apr; 28(7):2470-80. PubMed ID: 18227156
[TBL] [Abstract][Full Text] [Related]
17. E3 ubiquitin ligase casitas B-lineage lymphoma-b modulates T-cell anergic resistance via phosphoinositide 3-kinase signaling in patients with immune thrombocytopenia.
Liu L; Xiang Y; Shao L; Yuan C; Song X; Sun M; Liu Y; Zhang X; Du S; Hou M; Peng J; Shi Y
J Thromb Haemost; 2024 Apr; 22(4):1202-1214. PubMed ID: 38184203
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulence.
Balachandran P; Dragone L; Garrity-Ryan L; Lemus A; Weiss A; Engel J
J Clin Invest; 2007 Feb; 117(2):419-27. PubMed ID: 17235393
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes.
Veselits M; Tanaka A; Lipkowitz S; O'Neill S; Sciammas R; Finnegan A; Zhang J; Clark MR
PLoS One; 2014; 9(3):e89792. PubMed ID: 24651487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
